Nduma Basil N, Al-Ajlouni Yazan A, Njei Basile
Internal Medicine, Merit Health Wesley, Hattiesburg, USA.
Medicine, New York Medical College, New York, USA.
Cureus. 2023 Dec 15;15(12):e50601. doi: 10.7759/cureus.50601. eCollection 2023 Dec.
Fatty liver disease, also known as hepatic steatosis, poses a significant global health concern due to the excessive accumulation of fat within the liver. If left untreated, this condition can give rise to severe complications. Recent advances in artificial intelligence (AI, specifically AI-based ultrasound imaging) offer promising tools for diagnosing this condition. This review endeavors to explore the current state of research concerning AI's role in diagnosing fatty liver disease, with a particular emphasis on imaging methods. To this end, a comprehensive search was conducted across electronic databases, including Google Scholar and Embase, to identify relevant studies published between January 2010 and May 2023, with keywords such as "fatty liver disease" and "artificial intelligence (AI)." The article selection process adhered to the PRISMA framework, ultimately resulting in the inclusion of 13 studies. These studies leveraged AI-assisted ultrasound due to its accessibility and cost-effectiveness, and they hailed from diverse countries, including India, China, Singapore, the United States, Egypt, Iran, Poland, Malaysia, and Korea. These studies employed a variety of AI classifiers, such as support vector machines, convolutional neural networks, multilayer perceptron, fuzzy Sugeno, and probabilistic neural networks, all of which demonstrated a remarkable level of precision. Notably, one study even achieved a diagnostic accuracy rate of 100%, underscoring AI's potential in diagnosing fatty liver disease. Nevertheless, the review acknowledged certain limitations within the included studies, with the majority featuring relatively small sample sizes, often encompassing fewer than 100 patients. Additionally, the variability in AI algorithms and imaging techniques added complexity to the comparative analysis. In conclusion, this review emphasizes the potential of AI in enhancing the diagnosis and management of fatty liver disease through advanced imaging techniques. Future research endeavors should prioritize the execution of large-scale studies that employ standardized AI algorithms and imaging techniques to validate AI's utility in diagnosing this prevalent health condition.
脂肪性肝病,也称为肝脂肪变性,由于肝脏内脂肪过度堆积,已成为全球重大的健康问题。如果不加以治疗,这种疾病可能会引发严重的并发症。人工智能(AI,特别是基于AI的超声成像)的最新进展为诊断这种疾病提供了有前景的工具。本综述旨在探讨关于AI在诊断脂肪性肝病中作用的当前研究状况,特别关注成像方法。为此,我们在包括谷歌学术和Embase在内的电子数据库中进行了全面搜索,以识别2010年1月至2023年5月期间发表的相关研究,关键词包括“脂肪性肝病”和“人工智能(AI)”。文章选择过程遵循PRISMA框架,最终纳入了13项研究。这些研究利用了AI辅助超声,因为其具有可及性和成本效益,它们来自不同的国家,包括印度、中国、新加坡、美国、埃及、伊朗、波兰、马来西亚和韩国。这些研究采用了多种AI分类器,如支持向量机、卷积神经网络、多层感知器、模糊Sugeno和概率神经网络,所有这些都显示出了很高的精度。值得注意的是,一项研究甚至达到了100%的诊断准确率,凸显了AI在诊断脂肪性肝病方面的潜力。然而,该综述承认纳入研究存在某些局限性,大多数研究的样本量相对较小,通常涵盖不到100名患者。此外,AI算法和成像技术的差异增加了比较分析的复杂性。总之,本综述强调了AI通过先进成像技术在改善脂肪性肝病诊断和管理方面的潜力。未来的研究应优先开展大规模研究,采用标准化的AI算法和成像技术,以验证AI在诊断这种常见健康状况中的效用。